← Browse by Condition
Medical Condition
advanced hepatocellular carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 3
NCT06326502 Phase 1
Recruiting
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Enrollment
50 pts
Location
South Korea
Sponsor
Etnova Therapeutics Corp.
NCT07166406 Phase 3
Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Enrollment
252 pts
Location
United States
Sponsor
NRG Oncology